Accenture publishes the Life Sciences Technology Vision 2022 report

NEW YORK, August 22, 2022 — Accenture’s Life Sciences Technology Vision 2022 report explores technology trends that will transform the way biopharma and medtech companies solve manufacturing and device problems, improve equity in participation in clinical trials and will build more resilient supply chains to provide patients and healthcare professionals with more personalized experiences.

The metaverse is an evolving and expanding continuum in multiple dimensions, digital and physical, including technologies such as augmented reality, blockchain, artificial intelligence, digital twins, non-fungible tokens and smart devices. According to the report, life sciences leaders (91% of medtech executives and 85% of biopharma executives) expect the metaverse to have a positive impact on their organizations, and nearly half of biopharmacy respondents believe that the metaverse will have a breakthrough or transformative impact. about their organizations.

Petra Jantzer, global head of industry life sciences at Accenture, said: “We are in the early days of the metaverse and the technology innovations we implement today – the solutions, products and services that companies offer, how they develop them and distribute and how their organizations fundamentally operate them—they are the building blocks of the future of life sciences Industry leaders are pioneering a new digital future for how people and businesses interact, and many of the rules follow undefined. It is critical that life sciences companies take steps to proactively and responsibly shape the metaverse continuum.”

To help life sciences companies design, execute and accelerate their metaverse journeys, Accenture recently launched the Accenture Metaverse Continuum business group, which combines skilled metaverse professionals and market-leading capabilities in customer experience, digital commerce, augmented reality, blockchain, digital twins, artificial intelligence and computer vision.

The report explores four technology trends underpinning the metaverse continuum:

  • WebMe illustrates how the Internet is being reimagined with the metaverse as a platform for digital experiences that offer limitless places where people can gather and interact, and Web3 is reinventing how data can be owned and moved by individuals with the person and not with the platform. In the future, a new generation of digital devices will be integrated into the metaverse and could include smart technology in everyday objects such as appliances and “smart” cars that provide salient data on healthy human behaviors alongside medically regulated devices such as Donisi, which can simultaneously detect and analyze multiple bio-parameters.
  • The programmable world tracks how technology is moving through our physical environments in three layers: connected, experiential and material. Nearly nine in 10 of MedTech and biopharma executives surveyed believe physical environment programming will emerge as a competitive differentiator in their industry. Augmented reality, 5G, ambient computing, 3D printing and smart materials are converging in sophisticated ways, turning the physical world into an environment as intelligent, customizable and programmable as the digital one.
  • The Unreal explores the “unreal” qualities that are becoming fundamental to artificial intelligence (AI) and even data, making the synthetic seem authentic. Synthetic data is used to train AI models in a way that real-world data practically cannot or should not. Synthetic data can represent patient datasets for use in research, training, or other applications. This realistic (but unreal) data can be shared, maintaining the same statistical properties while protecting confidentiality and privacy. It can be developed to accommodate greater diversity to counteract bias, thereby overcoming the drawbacks of real-world data. More than nine-tenths of biopharma (92%) and MedTech (91%) executives report that their organization depends on AI technologies to function effectively.
  • Calculating the Impossible it is the emergence of a new class of machines – quantum computing – that stretches the limits of what computers can do. Problems that were once thought impossible to solve because they require computing large and complex datasets are now in the realm of the possible. Almost all biopharma (94%) and MedTech (96%) executives agree that their organization is pivoting in response to the unprecedented computational power that is available.

The Life Sciences Technology Vision 2022 report can be accessed here.

About Accenture

Accenture is a global professional services company with leading capabilities in digital, cloud and security. Combining unmatched experience and specialized skills across more than 40 industries, we offer strategy and consulting, technology and operations and Accenture Song services, all powered by the world’s largest network of advanced technology and intelligent operations centers . Our 710,000 people deliver on the promise of technology and human ingenuity every day, serving customers in more than 120 countries. We embrace the power of change to create value and shared success for our customers, people, shareholders, partners and communities.


Source: Accenture

Leave a Comment

Your email address will not be published.